Alume Biosciences’ $13 Million Series B Financing Round

Pillsbury Winthrop Shaw Pittman LLP advised Alume Biosciences on the deal.Alume Biosciences, a leader in the field of nerve-targeted diagnostics and therapeutics, announced a $13 million Series…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now